Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia

This study has been completed.
National Yang Ming University
Information provided by (Responsible Party):
Chung-Hua Hsu, Taipei City Hospital Identifier:
First received: May 20, 2011
Last updated: April 27, 2013
Last verified: April 2013
The aim of the study is to examine whether the extract of green tea is effective on type 2 diabetes and hyperlipidemia.

Condition Intervention Phase
Type 2 Diabetes
Dietary Supplement: Green tea extract
Dietary Supplement: Placebo
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Taipei City Hospital, Taipei, Taiwan

Resource links provided by NLM:

Further study details as provided by Taipei City Hospital:

Primary Outcome Measures:
  • Percent change of HOMA insulin resistance and TG [ Time Frame: 16 weeks ]

Secondary Outcome Measures:
  • Percent change of HbA1C and Cholesterol [ Time Frame: 16 weeks ]

Enrollment: 102
Study Start Date: May 2011
Study Completion Date: December 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: B formula
Dietary Supplement: Placebo
500 mg . one capsule of placebo, 3 times per day
Experimental: A formula
Green tea extract
Dietary Supplement: Green tea extract
500 mg . one capsule of green tea extract, 3 times per day
Other Name: EGCG: Green tea extract

Detailed Description:
Percent change Homa insulin resistance, cholesterol and triglycerol.

Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 20--69 years old
  • Type 2 diabetes for > one year
  • TG >= 150 mg/dl or LDL >= 100 mg/dl

Exclusion Criteria:

  • GPT > 80 mg/dl
  • Creatinine > 1.8 mg/dl
  • Pregnancy
  • AMI
  • Stroke
  • Operational or any not suitable patients diagnosis physician in charge
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01360567

Chung-Hua Hsu
Taipei, Taiwan, 886
Taipei City Hospital
Taipei, Taiwan, 886
Sponsors and Collaborators
Taipei City Hospital
National Yang Ming University
Principal Investigator: Chung-Hua Hsu, MD, PhD Taipei City Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Chung-Hua Hsu, chief medical officer, Taipei City Hospital Identifier: NCT01360567     History of Changes
Other Study ID Numbers: 100002-63-020
TCH-971103 ( Other Grant/Funding Number: CCMP100-RD-014 )
TCHIRB-971103 ( Other Grant/Funding Number: CCMP100-RD-014 )
Study First Received: May 20, 2011
Last Updated: April 27, 2013

Keywords provided by Taipei City Hospital:
green tea
type 2 diabetes

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Lipid Metabolism Disorders processed this record on May 25, 2017